145 related articles for article (PubMed ID: 38431782)
1. Integrating Patient-Reported Outcomes Into Prognostication in Gastroesophageal Cancer: Results of a Population-Based Retrospective Cohort Analysis.
Baccili Cury Megid T; Sharma D; Baskurt Z; Xiaolu Ma L; Wang X; Barron CC; Jang RW; Chen EX; Swallow CJ; Mesci A; Yeung J; Wong RKS; Brar SS; Veit-Haibach P; Kim J; Bach Y; Aoyama H; Elimova E
Oncologist; 2024 Apr; 29(4):316-323. PubMed ID: 38431782
[TBL] [Abstract][Full Text] [Related]
2. Patient-Reported Functional Status in Outpatients With Advanced Cancer: Correlation With Physician-Reported Scores and Survival.
Popovic G; Harhara T; Pope A; Al-Awamer A; Banerjee S; Bryson J; Mak E; Lau J; Hannon B; Swami N; Le LW; Zimmermann C
J Pain Symptom Manage; 2018 Jun; 55(6):1500-1508. PubMed ID: 29496534
[TBL] [Abstract][Full Text] [Related]
3. Utility of the revised Edmonton Symptom Assessment System (ESAS-r) and the Patient-Reported Functional Status (PRFS) in lung cancer patients.
Yogananda MN; Muthu V; Prasad KT; Kohli A; Behera D; Singh N
Support Care Cancer; 2018 Mar; 26(3):767-775. PubMed ID: 29027005
[TBL] [Abstract][Full Text] [Related]
4. Comparing the Ability of Physician-Reported Versus Patient-Reported Performance Status to Predict Survival in a Population-Based Cohort of Newly Diagnosed Cancer Patients.
Al-Rashdan A; Sutradhar R; Nazeri-Rad N; Yao C; Barbera L
Clin Oncol (R Coll Radiol); 2021 Jul; 33(7):476-482. PubMed ID: 33549463
[TBL] [Abstract][Full Text] [Related]
5. Are population-based patient-reported outcomes associated with overall survival in patients with advanced pancreatic cancer?
Dai WF; Beca J; Guo H; Isaranawatchai W; Schwartz D; Naipaul R; Arias J; Qiao Y; Gavura S; Redmond-Misner R; Ismail Z; Barbera L; Chan K
Cancer Med; 2020 Jan; 9(1):215-224. PubMed ID: 31736256
[TBL] [Abstract][Full Text] [Related]
6. Comparing Physician and Nurse Eastern Cooperative Oncology Group Performance Status (ECOG-PS) Ratings as Predictors of Clinical Outcomes in Patients with Cancer.
Neeman E; Gresham G; Ovasapians N; Hendifar A; Tuli R; Figlin R; Shinde A
Oncologist; 2019 Dec; 24(12):e1460-e1466. PubMed ID: 31227648
[TBL] [Abstract][Full Text] [Related]
7. Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg.
Berger AK; Zschaebitz S; Komander C; Jäger D; Haag GM
World J Gastroenterol; 2015 Apr; 21(16):4911-8. PubMed ID: 25945004
[TBL] [Abstract][Full Text] [Related]
8. Differences in Performance Status Assessment Among Palliative Care Specialists, Nurses, and Medical Oncologists.
Kim YJ; Hui D; Zhang Y; Park JC; Chisholm G; Williams J; Bruera E
J Pain Symptom Manage; 2015 Jun; 49(6):1050-1058.e2. PubMed ID: 25542550
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung Cancer.
McGee SF; Zhang T; Jonker H; Laurie SA; Goss G; Nicholas G; Albaimani K; Wheatley-Price P
Clin Lung Cancer; 2018 Jan; 19(1):e91-e99. PubMed ID: 28666762
[TBL] [Abstract][Full Text] [Related]
10. "How Long Have I Got?"-A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients with Advanced Cancer.
Simmons C; McMillan DC; Tuck S; Graham C; McKeown A; Bennett M; O'Neill C; Wilcock A; Usborne C; Fearon KC; Fallon M; Laird BJ;
Oncologist; 2019 Sep; 24(9):e960-e967. PubMed ID: 30975922
[TBL] [Abstract][Full Text] [Related]
11. Pre-screening of patient-reported symptoms using the Edmonton Symptom Assessment System in outpatient palliative cancer care.
Lee G; Kim HS; Lee SW; Park YR; Kim EH; Lee B; Hu YJ; Kim KA; Kim D; Cho HY; Kang B; Choi HJ
Eur J Cancer Care (Engl); 2020 Nov; 29(6):e13305. PubMed ID: 33016473
[TBL] [Abstract][Full Text] [Related]
12. Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance status.
Bergerot CD; Philip EJ; Bergerot PG; Hsu J; Dizman N; Salgia M; Salgia N; Vaishampayan U; Battle D; Loscalzo M; Dale W; Pal SK
Cancer; 2021 Feb; 127(3):354-358. PubMed ID: 33007114
[TBL] [Abstract][Full Text] [Related]
13. Nurse and physician inter-rater agreement of three performance status measures in palliative care outpatients.
Zimmermann C; Burman D; Bandukwala S; Seccareccia D; Kaya E; Bryson J; Rodin G; Lo C
Support Care Cancer; 2010 May; 18(5):609-16. PubMed ID: 19629537
[TBL] [Abstract][Full Text] [Related]
14. 153Sm-EDTMP and 177Lu-EDTMP are equally safe and effective in pain palliation from skeletal metastases.
Taheri M; Azizmohammadi Z; Ansari M; Dadkhah P; Dehghan K; Valizadeh R; Assadi M
Nuklearmedizin; 2018 Sep; 57(5):174-180. PubMed ID: 30267399
[TBL] [Abstract][Full Text] [Related]
15. The impact of routine Edmonton Symptom Assessment System (ESAS) use on overall survival in cancer patients: Results of a population-based retrospective matched cohort analysis.
Barbera L; Sutradhar R; Seow H; Mittmann N; Howell D; Earle CC; Li Q; Thiruchelvam D
Cancer Med; 2020 Oct; 9(19):7107-7115. PubMed ID: 32794634
[TBL] [Abstract][Full Text] [Related]
16. The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
Takahashi M; Takahashi M; Komine K; Yamada H; Kasahara Y; Chikamatsu S; Okita A; Ito S; Ouchi K; Okada Y; Imai H; Saijo K; Shirota H; Takahashi S; Mori T; Shimodaira H; Ishioka C
PLoS One; 2017; 12(6):e0179694. PubMed ID: 28640844
[TBL] [Abstract][Full Text] [Related]
17. Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung Cancer.
Tjong MC; Doherty M; Tan H; Chan WC; Zhao H; Hallet J; Darling G; Kidane B; Wright FC; Mahar A; Davis LE; Delibasic V; Parmar A; Mittmann N; Coburn NG; Louie AV
Oncologist; 2021 Oct; 26(10):e1800-e1811. PubMed ID: 34216415
[TBL] [Abstract][Full Text] [Related]
18. Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer.
Jarnagin JX; Saraf A; Baiev I; Chi G; van Seventer EE; Mojtahed A; Allen JN; Clark JW; Blaszkowsky L; Giantonio BJ; Weekes CD; Klempner SJ; Franses JW; Roeland EJ; Goyal L; Siravegna G; Horick N; Corcoran RB; Nipp RD; Parikh AR
JAMA Netw Open; 2023 Nov; 6(11):e2343512. PubMed ID: 37976066
[TBL] [Abstract][Full Text] [Related]
19. Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600-Mutated Metastatic Melanoma: Pooled Analysis of 4 Randomized Clinical Trials.
Hauschild A; Larkin J; Ribas A; Dréno B; Flaherty KT; Ascierto PA; Lewis KD; McKenna E; Zhu Q; Mun Y; McArthur GA
JAMA Oncol; 2018 Oct; 4(10):1382-1388. PubMed ID: 30073321
[TBL] [Abstract][Full Text] [Related]
20. A comparison of acute patient-reported outcomes in breast cancer patients with and without regional nodal irradiation using the ESAS and PRFS tool.
Behroozian T; Milton L; Zhang L; Lou J; Shariati S; Karam I; Chow E
Support Care Cancer; 2023 Apr; 31(5):279. PubMed ID: 37074458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
